![]() |
市場調查報告書
商品編碼
1946030
全球生物催化劑和酵素化學品市場:預測(至2034年)-按類型、原料、應用和地區分析Bio-Catalyst & Enzyme Chemical Market Forecasts to 2034 - Global Analysis By Type (Hydrolases, Oxidoreductases, Transferases, Lyases, Isomerases and Ligases), Source, Application and By Geography |
||||||
根據 Stratistics MRC 的研究,預計到 2026 年,全球生物催化劑和酵素化學品市場將達到 7.8661 億美元,在預測期內以 6.4% 的複合年成長率成長,到 2034 年將達到 12.9209 億美元。
酵素製劑和生物催化劑在加速生物化學過程中發揮至關重要的作用,同時也是傳統化學催化劑的環保替代品。它們廣泛應用於製藥、食品生產、紡織和生質燃料製造等領域,能夠提高效率、增加產量並降低能耗。其精準的作用能夠達到選擇性反應,減少不必要的副產物和對生態系的負面影響。隨著各產業日益關注永續和環境友善解決方案,生物催化劑和酵素製劑的重要性也日益凸顯。持續的研發工作不斷拓展其工業應用,使其成為高效、環保和先進的化學及生物技術製程中不可或缺的組成部分。
根據經濟複雜性觀察站(OEC)的數據,預計2024年全球酵素(HS編碼3507)貿易額將達到76.3億美元,較2023年成長4.9%。丹麥將成為最大的出口國,出口額達17.9億美元,而美國將成為最大的進口國,進口額達9.94億美元。過去五年,酵素貿易額年平均成長率為6.51%,凸顯了整個產業的穩定需求。
對永續和環保製程的需求日益成長
人們日益增強的環境保護和永續意識正在推動生物催化和酶促化學品的發展。傳統的化學製程往往會產生污染物並消耗大量能源,迫使各行業採用更清潔的替代方案。酵素能夠實現精準高效的反應,並將廢棄物降至最低,從而支持永續性目標和法規遵循。此外,消費者對環保產品的需求不斷成長,也推動了工業界對這些化學品的應用。致力於減少碳排放並滿足日益嚴格的環境標準的企業越來越依賴生物催化和酵素化學品。因此,這些化學品正成為全球實現清潔、安全和永續工業製造流程的關鍵要素。
高昂的生產成本
生物催化劑和酵素化學品市場面臨的主要限制因素是高昂的生產成本。酵素的生產需要先進的技術、嚴格的條件和專業人員,這推高了營運成本。大規模生產高純度酵素需要對生物反應器、設備和品管進行大量投資。由於這些高成本,酶基產品通常比傳統的化學催化劑更昂貴,限制了其在成本敏感產業的應用。儘管需求不斷成長,但高昂的經濟負擔阻礙了大規模部署。該行業必須謹慎權衡成本和永續性,因為定價仍然是一個重大挑戰,限制市場成長,並減緩了生物催化劑和酵素化學品的廣泛應用。
擴大食品飲料業的招聘
消費者對潔淨標示、天然來源和營養食品的需求日益成長,為生物催化劑和酵素創造了巨大的成長潛力。酵素能夠提高加工效率,改善口感、質地和保存期限,並降低能耗。機能性食品、膳食補充劑和植物來源替代品的激增,進一步擴大了酵素的應用範圍。此外,酵素解決方案還有助於實現環保的生產方式,並符合相關法規標準。隨著全球消費者越來越重視食品品質和健康,生產商正積極採用酵素技術。這為生物催化劑和酵素生產商提供了巨大的機遇,使其能夠鞏固市場地位,並滿足創新食品飲料行業不斷變化的需求。
激烈的市場競爭
酵素和生物催化劑市場面臨來自全球領導企業和區域性企業的激烈競爭。大規模跨國公司憑藉先進技術、忠實的基本客群和廣泛的分銷網路,提高了中小企業的准入門檻。同時,不斷湧現的創新Start-Ups推出的新型酵素解決方案加劇了競爭,導致價格壓力上升和利潤率下降。為了保持競爭力,企業必須持續投資於研發、行銷和技術創新。這種高度競爭的環境可能導致產業重組、價格競爭加劇和利潤率下降,威脅盈利和長期生存能力。因此,激烈的市場競爭仍然是酵素和生物催化劑行業穩定和成長面臨的重大威脅。
新冠疫情對酵素和生物催化劑市場造成了重大影響,擾亂了全球供應鏈、生產和物流。封鎖和旅行限制導致原料採購延遲,生產放緩,限制了工業和食品行業的成長。另一方面,由於酵素在診斷、疫苗生產和治療中至關重要,製藥和醫療保健行業的需求激增,部分抵消了其他行業的下滑。疫情也刺激了對生物技術研發和用於醫療應用的酵素開發的投資。總而言之,新冠疫情為市場帶來了挑戰和機遇,重塑了產業優先事項,並凸顯了生物催化劑和酵素在醫學和創新領域的關鍵作用。
在預測期內,水解酵素細分市場預計將佔據最大的市場佔有率。
由於水解酶具有廣泛的工業應用和高效催化水解反應的能力,預計在預測期內,水解酶細分市場將佔據最大的市場佔有率。它被應用於製藥、食品加工、生質燃料和紡織等多個領域,有助於提高生產速度、產量和品質。水解酶能夠分解脂肪、蛋白質和碳水化合物等複雜的生物分子,這在眾多製程中至關重要。水解酶的特異性、環境友善性和在溫和操作條件下的高效性進一步促進了其應用。透過持續的技術進步和研究,水解酵素的應用範圍不斷擴大,鞏固了其市場主導地位,使其成為全球生物催化劑和酶化學品市場中最重要的細分市場。
預計在預測期內,微生物領域將呈現最高的複合年成長率。
在預測期內,受成本效益、擴充性和適應性等因素的驅動,微生物來源酶預計將呈現最高的成長率。大規模微生物發酵能夠生產品質穩定、供應充足的酵素。其應用範圍廣泛,涵蓋製藥、生質燃料、食品加工和化學等領域,滿足了工業界對永續和高性能催化劑的需求。生物技術和基因工程的進步正在提高酵素的穩定性、活性和特異性,進一步拓展其應用範圍。隨著對環境友善和可再生工業流程的日益重視,微生物來源酶的應用正在加速發展,使其成為全球生物催化劑和酶化學品市場的主要驅動力。
在整個預測期內,北美預計將保持最大的市場佔有率,這得益於其強大的工業基礎和先進的生物技術能力。主要生產商的存在及其產品在製藥、生質燃料、食品加工和化學等領域的廣泛應用,鞏固了其市場主導地位。政府支持、研發投入以及促進永續工業實踐的法規,進一步推動了酵素的應用。該地區受益於持續創新、不斷成長的醫療需求以及對環保生產方式的重視。技術進步、產業多元化和消費者意識的提高,共同使北美成為最重要的區域市場參與者,佔據全球生物催化劑和酵素化學品市場最大的佔有率。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於快速的工業成長、食品和製藥行業的擴張以及生物技術投資的增加。消費者對永續和環保產品的意識不斷提高、可支配收入的增加以及政府支持綠色生產的政策,都在推動相關產品的普及。中國、印度和日本等國家在生質燃料、食品加工和製藥領域對酵素解決方案的需求強勁。技術進步、研發活動的加強以及有利的監管環境進一步促進了市場擴張。因此,亞太地區正在崛起為成長最快的地區,為生物催化劑和酵素化學品公司提供了巨大的發展機會。
According to Stratistics MRC, the Global Bio-Catalyst & Enzyme Chemical Market is accounted for $786.61 million in 2026 and is expected to reach $1292.09 million by 2034 growing at a CAGR of 6.4% during the forecast period. Enzyme chemicals and bio-catalysts play a crucial role in speeding up biochemical processes while serving as environmentally friendly substitutes for conventional chemical catalysts. They are extensively applied in sectors like pharmaceuticals, food production, textiles, and biofuel manufacturing, improving efficiency, increasing yields, and lowering energy requirements. Their precise action enables selective reactions, reducing unwanted by-products and ecological harm. As industries focus on sustainable and green solutions, the importance of bio-catalysts and enzyme chemicals continues to rise. Ongoing research and technological developments are broadening their industrial applications, making them indispensable for efficient, eco-conscious, and advanced chemical and biotechnological operations.
According to the Observatory of Economic Complexity (OEC), data shows that global trade in enzymes (HS Code 3507) reached $7.63 billion in 2024, reflecting a 4.9% increase from 2023. Denmark was the top exporter at $1.79 billion, while the United States was the largest importer at $994 million. Over the past five years, enzyme trade has grown at an annualized rate of 6.51%, highlighting steady demand across industries.
Growing demand for sustainable and green processes
Heightened awareness of environmental protection and sustainable practices is fueling the growth of bio-catalysts and enzyme chemicals. Conventional chemical processes often produce pollutants and consume significant energy, prompting industries to adopt cleaner alternatives. Enzymes enable precise and efficient reactions while minimizing waste, supporting sustainability targets and regulatory compliance. Additionally, growing consumer demand for eco-friendly products drives industrial adoption. Companies striving to lower carbon emissions and meet stricter environmental standards increasingly rely on bio-catalysts and enzymes. Consequently, these chemicals are becoming crucial for achieving cleaner, safer, and more sustainable industrial manufacturing processes worldwide.
High production costs
High production expenses are a key limitation for the bio-catalyst and enzyme chemical market. Enzyme manufacturing demands sophisticated technology, strict conditions, and specialized workforce, driving up operational costs. Producing large quantities of high-purity enzymes requires significant investment in bioreactors, equipment, and quality control. These elevated costs often make enzyme-based products more expensive than traditional chemical catalysts, reducing adoption in cost-sensitive industries. Despite increasing demand, the high financial burden limits large-scale implementation. Industries must carefully manage cost versus sustainability priorities, making price a significant challenge that constrains market growth and delays broader integration of bio-catalysts and enzyme chemicals.
Increasing adoption in food & beverage innovations
Rising consumer demand for clean-label, natural, and nutritious food products creates growth potential for bio-catalysts and enzymes. Enzymes improve processing efficiency, enhance taste, texture, and shelf life, and lower energy usage. The surge in functional foods, nutraceuticals, and plant-based alternatives widens enzyme application possibilities. Additionally, enzyme solutions support environmentally friendly production practices and compliance with regulatory standards. As global consumers increasingly prioritize food quality and health, manufacturers are adopting enzyme-based technologies. This provides considerable opportunities for bio-catalyst and enzyme producers to strengthen their market position and cater to the evolving needs of the innovative food and beverage industry.
Intense market competition
The enzyme and bio-catalyst market is challenged by strong competition from both global leaders and regional players. Large multinationals benefit from advanced technologies, loyal clients, and extensive distribution, creating hurdles for smaller companies. Meanwhile, innovative startups introducing new enzyme solutions heighten rivalry, resulting in pricing pressures and reduced profits. Companies must constantly invest in R&D, marketing, and technological improvements to sustain competitiveness. This highly competitive environment can trigger consolidation, aggressive pricing, and margin erosion, threatening profitability and long-term viability. Consequently, intense market competition remains a significant threat to the stability and growth of enzyme and bio-catalyst businesses.
The COVID-19 outbreak had a notable effect on the enzyme and bio-catalyst market, disrupting global supply chains, manufacturing, and logistics. Lockdowns and movement restrictions delayed raw material procurement and slowed production, limiting growth in industrial and food sectors. Conversely, demand surged in pharmaceuticals and healthcare, as enzymes were critical in diagnostics, vaccine production, and therapeutics, partially counterbalancing declines elsewhere. The pandemic also spurred investments in biotechnology research and enzyme development for medical applications. Overall, COVID-19 both challenged and created opportunities for the market, reshaping industry priorities and emphasizing the vital role of bio-catalysts and enzymes in healthcare and innovation.
The hydrolases segment is expected to be the largest during the forecast period
The hydrolases segment is expected to account for the largest market share during the forecast period due to their broad industrial utility and capacity to catalyze hydrolysis reactions efficiently. They find applications across pharmaceuticals, food processing, biofuels, and textiles, improving production speed, output, and quality. Their capability to degrade complex biomolecules like fats, proteins, and carbohydrates makes them essential in numerous processes. The enzymes' specificity, environmentally friendly properties, and effectiveness under mild operating conditions enhance their adoption. Ongoing advancements and research continue to broaden hydrolase applications, reinforcing their dominance and establishing them as the most significant segment within the global bio-catalyst and enzyme chemical market.
The micro-organism derived segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the micro-organism derived segment is predicted to witness the highest growth rate, driven by its cost efficiency, scalability, and adaptability. Large-scale microbial fermentation enables the production of enzymes with consistent quality and abundant supply. Their broad applications span pharmaceuticals, biofuels, food processing, and chemicals, fulfilling industrial demand for sustainable and high-performance catalysts. Advances in biotechnology and genetic engineering enhance enzyme stability, activity, and specificity, further expanding applications. The increasing emphasis on green and renewable industrial processes accelerates the adoption of micro-organism derived enzymes, establishing this segment as the leading growth driver in the global bio-catalyst and enzyme chemical market.
During the forecast period, the North America region is expected to hold the largest market share, driven by a strong industrial base and advanced biotechnology capabilities. Leading manufacturers and widespread applications in pharmaceuticals, biofuels, food processing, and chemical sectors contribute to its dominance. Government support, R&D investments, and regulations favoring sustainable industrial practices further promote enzyme adoption. The region benefits from continuous innovation, growing healthcare requirements, and emphasis on environmentally friendly production methods. With a blend of technological advancement, industrial diversification, and high consumer awareness, North America remains the most significant regional player, accounting for the largest portion of the global bio-catalyst and enzyme chemical market.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to rapid industrial growth, expanding food and pharmaceutical sectors, and increasing biotechnology investments. Rising consumer awareness of sustainable and eco-friendly products, higher disposable incomes, and supportive government policies for green production fuel adoption. Countries like China, India, and Japan show strong demand for enzyme solutions in biofuels, food processing, and pharmaceuticals. Technological progress, enhanced research initiatives, and favourable regulations further drive market expansion. Consequently, Asia-Pacific is emerging as the region with the fastest growth, offering significant opportunities for bio-catalyst and enzyme chemical companies.
Key players in the market
Some of the key players in Bio-Catalyst & Enzyme Chemical Market include AB Enzymes, BASF SE, Codexis Inc., DuPont de Nemours Inc., Dyadic International Inc., DSM (dsm-firmenich), Lonza Group Ltd., Novozymes A/S (Novonesis), Sapporo Enzyme Co. Ltd., Soufflet Group, Amano Enzyme Inc., Chr. Hansen, Biocatalysts Limited, Prozomix Limited, Advanced Enzyme Technologies, Agrivida Inc., Iogen Corporation and MetGen Oy.
In August 2025, DuPont de Nemours, Inc., The Chemours Company and Corteva, Inc. announced a settlement to comprehensively resolve all pending environmental and other claims by the State of New Jersey against the Companies in various litigation matters and other state directives. The Settlement will resolve all legacy contamination claims related to the companies' current and former operating sites and claims of statewide PFAS contamination unrelated to those sites, including from the use of aqueous film forming foam.
In July 2025, BASF and Equinor have signed a long-term strategic agreement for the annual delivery of up to 23 terawatt hours of natural gas over a ten-year period. The contract secures a substantial share of BASF's natural gas needs in Europe. This agreement further strengthens our partnership with BASF. Natural gas not only provides energy security to Europe but also critical feedstock to European industries.
In July 2024, AB Enzymes is delighted to announce the signing of a rental contract for our future global headquarters at KALA | Central Campus Darmstadt. This strategic relocation marks a significant milestone in our growth journey, providing a modern and scalable environment to support our ambitious expansion plans. The new headquarters will span over 7,300 m2 of customised laboratory and office space, constituting more than 70% of the main building at the new location, with a long-term green lease agreement extending for the next 20 years.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.